Delivery Order SPE2DB24D8002-SPE2DB25FJNZG
Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $3,351.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a range of pharmaceutical products, medical supplies,...
- The Defense Logistics Agency (DLA) awarded a $3,689.76 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This order is part of Dakota Drug's $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and simulation equipment for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,566.52 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML. This award was made under contract SPE2DX24F7E3E, with a period of performance through June 24, 2024. Dakota Drug, Inc. is an experienced prime contractor that specializes in providing a wide range of pharmaceutical products, medical supplies, and...
- The Defense Logistics Agency (DLA) awarded a $1,828.50 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4565765799 - MOUNJARO 10 MG/0.5 ML PEN 0.5ML. This contract award, identified as SPE2DB24FJTMQ, has an ultimate completion date of September 9, 2024. Dakota Drug, Inc. is a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,504.35 contract is for the supply of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to provide a comprehensive range of pharmaceutical products,...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,731.97 contract is for the provision of Mounjaro 15 mg/0.5 ml pen 0.5 ml, a prescription medication. This delivery order contract has an ultimate completion date of April 23, 2024 and was awarded on April 22, 2024. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,215.04 firm fixed price delivery order is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML, with a completion date of May 30, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's...
- This federal contract award, valued at $2,694.90, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a delivery order for the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of August 30, 2024 and is structured as a firm fixed-price agreement. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The fixed-price contract has a ceiling value of $6,350.45 and a period of performance through March 10, 2025. Dakota Drug, Inc. is an established federal contractor, holding a large Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00 to provide a wide range...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,172.90 and a period of performance through October 18, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to...